The American Society of Hematology (ASH) annual meeting is being held December 1-4, 2018 in San Diego, CA. There is a guide at: xconomy.com/national/2018/1...
ASH 2018: A Guide to the Latest for Blood-Born... - CLL Support
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
Written by
wmay13241
To view profiles and participate in discussions please or .
Read more about...
8 Replies
•
Thank you, very helpful!
Imbruvica saved my life!
Thanks.
Jm954Administrator
I would love to go .......
My wife’s haematologist from Melbourne, Australia attending this to hear more about ibrutinib plus rituximab combination. Wife starting on ibrutinib after he gets back for she didn’t respond positively to 2 cycles of FCR.
First diagnosed with NHL (SLL) in 2008, treated with CHOP+R then returned as CLL in 2013, treated with CVP+R, now returned 2018. Also been receiving IgG infusions regularly.
Let’s hope the ASH conference reports plenty of encouraging options.
Not what you're looking for?
You may also like...
ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance
with Dr. Kipps at ASH 2018, he discusses resistance and how to possibly avoid it:...
ASH 2018: ECOG trial shows superiority of Ibrutinib and rituximab over FCR
patients <70 years old..
For more see:...
Late breaking CLL abstract at ASH 2018 (FCR vs IR for untreated younger patients)
https://ash.confex.com/ash/2018/webprogram/Paper120779.html
CONCLUSIONS: The combination of...
ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of venetoclax for CLL
Today we posted on ASH 2018: Dr. Lindsey Roeker research from ASH 2018 on real world use of...
Very Quick Day 1 Wrap from ASH 2018
None of the research has been presented at ASH 2018 in San Diego, but there is already a buzz about...